Key Highlights

• Nvidia has injected capital into Thinking Machines Lab, the artificial intelligence venture led by ex-OpenAI CTO Mira Murati (investment amount undisclosed)
• A strategic multi-year collaboration between the companies was revealed on Tuesday
• Thinking Machines plans to implement a minimum of one gigawatt worth of Nvidia’s Vera Rubin infrastructure
• The rollout is scheduled to begin in early next year
• Following a $2B capital raise in July 2025, Thinking Machines achieved a $10B valuation

Nvidia has taken an equity position in Thinking Machines Lab while establishing a comprehensive multi-year strategic alliance with the AI company. The partnership details emerged Tuesday morning.

Neither organization revealed the precise dollar amount of Nvidia’s equity stake.

Under the terms of this collaboration, Thinking Machines will integrate a minimum of one gigawatt of Nvidia’s cutting-edge Vera Rubin infrastructure. This computing power will fuel the company’s advanced model development efforts and platform operations.

According to Thinking Machines, the Vera Rubin systems are slated to go live early in the coming year.

Mira Murati established Thinking Machines Lab after her tenure as Chief Technology Officer at OpenAI. The company’s mission centers on delivering scalable, customizable artificial intelligence solutions for corporate clients, academic institutions, and scientific organizations.

In a prepared statement, Jensen Huang, who founded and leads Nvidia as CEO, commented: “Thinking Machines has assembled an exceptional team dedicated to pushing AI boundaries forward. We’re excited to collaborate with Thinking Machines as they pursue their compelling vision for AI’s evolution.”

Murati offered this response: “NVIDIA’s innovations form the bedrock of our entire industry. This collaboration enhances our ability to develop AI systems that users can customize and truly own.”

A $10 Billion Valuation

This partnership doesn’t mark Nvidia’s initial engagement with Thinking Machines. The chipmaker participated in the startup’s $2B financing round during July 2025, which established the company’s valuation at $10B.

Andreessen Horowitz (a16z) spearheaded that funding round, with additional backing from Nvidia, AMD, ServiceNow, and Cisco Systems.

Tuesday’s disclosure elevates the connection beyond simple investment to a comprehensive strategic partnership framework.

The agreement encompasses collaborative development of training and inference infrastructure optimized explicitly for Nvidia’s chip architectures.

Vera Rubin Takes Center Stage

Nvidia’s Vera Rubin platform represents the company’s latest-generation GPU infrastructure, and this agreement positions a gigawatt-scale implementation as a cornerstone element.

A gigawatt represents significant energy allocation — highlighting the massive scale required for cutting-edge AI model development today.

According to Thinking Machines, the Vera Rubin computing infrastructure will serve as the backbone for developing AI systems that users can tailor and engage with hands-on.

The collaboration aims to broaden accessibility to advanced AI capabilities and open-source models throughout enterprise and academic environments.

Nvidia maintains investment positions across numerous AI ventures and continues strengthening industry relationships through semiconductor supply contracts combined with ownership stakes.

The Thinking Machines agreement represents another addition to this portfolio, distinguished by its gigawatt-level hardware deployment obligation.

Trust Wallet has rolled out a proactive defense against address poisoning, introducing an automated screening feature that checks destination addresses against a live database of known scam and lookalike wallets. The noncustodial wallet provider said the protection will run in the background as users initiate transfers, aiming to thwart attempts to misdirect funds to illicit addresses. The rollout covers 32 Ethereum Virtual Machine-compatible chains at launch, including Ethereum, BNB Smart Chain, Polygon, Optimism, Arbitrum, Avalanche and Base, with the team signaling plans to expand over time. The move comes as the ecosystem contends with increasingly sophisticated phishing attempts that rely on users copying and pasting addresses from their transaction history.

Trust Wallet described address poisoning as among the crypto space’s fastest-growing threats, citing figures that place the total number of attacks at over 225 million and losses nearing $500 million to date. In address poisoning scams, perpetrators typically send a harmless, small amount to a target to establish a history, then capitalize on users who replicate addresses from their own transaction history, inadvertently sending larger sums to the attacker’s wallet. The new screening mechanism seeks to disrupt this attack chain by preventing outbound transfers to detected poison addresses before they are executed.

Beyond automated checks, the broader industry has been pushing for preemptive safeguards across wallets. Notably, several wallets already employ transaction-filtering tools designed to curb malicious transfers—for instance, Rabby Wallet, Zengo Wallet and Phantom Wallet have each introduced similar layers of screening to reduce exposure to scam addresses. The emphasis on preventative controls mirrors growing calls for a more defensive stance from the wallet ecosystem, especially as attackers increasingly rely on social engineering and lookalikes that mimic legitimate counterparts.

The topic has taken on renewed urgency in light of high-profile incident data. In December 2025, a single USDt (USDT) transfer tied to a poisoning scheme underscored the potential scale of losses, prompting calls from industry figures for more robust wallet-level defenses. Analysts and security researchers have long argued that users should not copy addresses from transaction histories, a practice that continues to contribute to successful exploits. Security firm Hacken has highlighted the importance of circumventing copy-paste habits as part of a multi-layered defense strategy.

Security researchers have pointed to the conflicts between convenience and protection in wallet design. The push for stricter verification aligns with expectations that wallets should act as the first line of defense—filtering out poison addresses and preventing users from inadvertently participating in scams. Some commentators have called for wallets to proactively block any receiving address that appears on a known poison list, a stance that aligns with broader calls for universal adoption of blockchain-querying checks at the point of interaction.

In parallel, discussions around address poisoning—both the technical mechanisms and the user-behavior patterns it exploits—continue to evolve. The episode underlines why exchanges, wallets and service providers alike must invest in robust address-checking capabilities, while users remain urged to verify recipient addresses through independent channels and avoid relying solely on transaction histories when copying addresses from trusted sources. As the ecosystem expands, the balance between user experience and security will remain a focal point for developers and regulators alike.

Why it matters

The introduction of address-poisoning protection marks a meaningful step in reducing on-chain losses and encouraging safer transaction practices across major EVM networks. For users, the feature represents a real-time safety net that can prevent inadvertent transfers to illicit wallets if a recipient address matches a known scam pattern or closely resembles a legitimate one. For builders and wallet providers, it sets a benchmark for proactive risk management and cross-wallet collaboration on threat intelligence, potentially reducing the volume of successful attacks that rely on social engineering and address lookalikes.

From a market perspective, the development reinforces the idea that security enhancements are increasingly becoming a differentiator among wallet ecosystems. As hackers refine their techniques, the emphasis shifts from purely cosmetic features to verifiable protections that can be audited and verified by users and independent researchers. The industry’s collective response—combining automated screening, user education and responsible disclosure—could contribute to a more resilient infrastructure over time, even as the crypto landscape remains sensitive to regulatory signals and macro risk sentiment.

For investors and users, this shift underscores the importance of risk management in wallet selection and usage. While no single protection can eliminate all threats, multi-layered defenses—complemented by best practices such as avoiding address copy-paste from transaction histories—can materially reduce exposure to address-poisoning schemes. The broader narrative is one of maturation: as wallets adopt more rigorous checks, the friction between speed and security may gradually tilt toward safer, more reliable user experiences.

What to watch next

• Expansion of the poisoned-address database to cover additional chains beyond the initial 32 EVM-compatible networks, with a timeline for rollout on non-EVM platforms.
• Independent audits or third-party attestations validating the accuracy and speed of the destination-address screening feature.
• Adoption metrics across wallets that implement similar protections, including user feedback and impact on attempted phishing campaigns.
• Updates from Trust Wallet or partner security teams regarding any zero-day findings or refinements to the poisoning-detection database.

Sources & verification

• Trust Wallet official announcement: address poisoning protection and rollout details.
• On-chain data and public logs illustrating address-poisoning incidents (e.g., notable large transfers cited in December 2025).
• Binance Square commentary by Changpeng Zhao advocating universal poison-address checks across wallets.
• Security research from Hacken’s Extractor team on best practices not to copy addresses from history.
• Industry coverage of Rabby, Zengo, and Phantom Wallets’ transaction-filtering approaches.

Trust Wallet rolls out address poisoning protection across 32 EVM chains

Trust Wallet has introduced a proactive defense against address poisoning by adding a destination-address screening feature that checks outgoing transfers against a live database of known scam and lookalike wallets. The aim is to stop users from accidentally sending funds to illicit addresses before the transaction is confirmed. The company emphasized that the protection operates automatically, running in real time as a user initiates a transfer. The initial scope includes 32 EVM-compatible networks, with Ethereum (CRYPTO: ETH) at the forefront, along with BNB Smart Chain, Polygon, Optimism, Arbitrum, Avalanche and Base. The firm noted that address-poisoning attacks have emerged as a fast-growing threat within crypto markets, and it cited figures indicating more than 225 million attacks and roughly $500 million in confirmed losses to date.

Address poisoning, a form of phishing, exploits the habit of users copying and pasting addresses from transaction histories—a behavior that can enable attackers to divert funds to malicious wallets. By cross-referencing recipient addresses with a database of poison addresses, Trust Wallet’s system can halt transactions before they leave a user’s control. This approach aligns with broader industry moves toward preemptive risk controls, particularly as scammers increasingly rely on social engineering and ambiguous address representations to mislead victims.

Industry observers point to complementary protections already available across wallets. Rabby Wallet, Zengo Wallet and Phantom Wallet have implemented early-warning systems or blacklist-based checks aimed at stopping transfers to flagged addresses. The emphasis on prevention reflects a broader trend toward user-centric security features that do not rely solely on post-incident recovery. In tandem with these protections, security researchers and users alike continue to advocate for best practices, such as avoiding direct copying of addresses from transaction histories and verifying recipients through independent channels.

The December 2025 incident involving a USDt (USDT) transfer underscored the ongoing risk, drawing attention to the need for wallet-level defenses that can catch poisoned addresses before funds move. Industry voices have stressed that wallets should not display or reproduce harmful transactions in the first place, a stance echoed by prominent figures who argue for a universal, automated filter at the point of interaction. While no solution is flawless, the convergence of automated screening, user education and cross-wallet sharing of threat-intelligence signals a maturing security posture across the crypto ecosystem.

As the rollout unfolds, the crypto community will be watching for how well these protections scale across networks and how quickly users adapt to new prompts or warnings when initiating transfers. The goal is a safer user experience that preserves the speed and convenience that attract new participants, while delivering meaningful guardrails against one of the space’s oldest and most persistent attack vectors. In a rapidly evolving threat landscape, Trust Wallet’s move signals a continued push toward stronger, more transparent security practices that could shape wallet design choices for years to come.

Anthropic just picked a fight with its biggest potential customer.

The AI company behind Claude filed a lawsuit Monday in the U.S. District Court for the Northern District of California naming the Departments of Treasury, Commerce, State, Health and Human Services, Veterans Affairs, the General Services Administration, and several other federal agencies as defendants.

Anthropic says the U.S. government effectively blacklisted its AI systems from federal procurement and did it without following any of the legal procedures required to actually ban a vendor.

It says there was a lack of formal determination, interagency review, documented evidence, and no evaluation of less restrictive alternatives like conditional approval or security audits.

According to the complaint, officials justified the restrictions internally on national security and supply-chain grounds, then let the directive spread informally through centralized procurement channels until Anthropic was locked out of federal contracting across the board.

The timing makes this more than a procurement dispute.

The U.S. government is in the middle of the largest AI adoption push in federal history, using OpenAI’s ChatGPT as its tool of choice. Agencies are deploying generative AI for cybersecurity, intelligence analysis, administrative automation, and internal decision-making. The contracts are large, multi-year, and increasingly central to how the government operates.

Getting locked out of that market isn’t a minor commercial setback, but an existential competitive problem for any AI company that wants to be taken seriously at the institutional level.

Anthropic is asking the court to declare the restrictions unlawful and block agencies from enforcing them. If it wins, the ruling would reopen federal procurement and potentially set a precedent on how far agencies can go when restricting AI vendors on national security grounds without following their own rules.

The government hasn’t publicly responded to the filing, but an Axios report on Tuesday noted the White House was preparing an executive order formally instructing the federal government to rip out Anthropic’s AI from its operations, citing sources familiar with the matter.

X Money will be launching its early public access as soon as next month, Elon Musk confirmed.

The much-anticipated financial app, planned and developed by the popular social media platform X (formerly Twitter), is coming to market sooner than some may have anticipated.

Elon Musk posted on X to reveal that the app’s early public access launch will take place as soon as next month.

𝕏 Money early public access will launch next month

— Elon Musk (@elonmusk) March 10, 2026

Why it Matters for Crypto?

As CryptoPotato reported earlier, Musk’s vision of transforming social media into an “everything app” has been gradually taking shape with the development of X Money. The latter is supposed to be a new payments feature designed to bring financial services directly to the platform.

Up until this moment, Musk said that the app was running in a closed internal beta.

Early screenshots of the popular actor William Shatner suggested that the app may include features such as a debit card with cashback, as well as tools for sending and receiving payments.

One of the biggest questions surrounding X Money, however, is whether or not it will support cryptocurrencies. Musk, who has frequently influenced crypto markets in the past, particularly through his comments about Dogecoin, as well as his decision to integrate Bitcoin payments for Tesla purchases, as well as to hold BTC on Tesla’s balance sheet, has hinted at broader financial capabilities for the platform.

You may also like:

He even recently amplified a post that described potential services, such as crypto support, and commented that the overall initiative will be big.

It’s worth noting, however, that there’s no official confirmation of whether such integrations will be featured.

Shiba Inu Coin price rose by 7% on March 10 as the crypto market rallied and as the burn rate jumped by over 162%.

Shiba Inu (SHIB) token was trading at $0.0000058, a few points slightly above the year-to-date low of $0.00000525. It remains 83% below its highest point in 2025.

On the positive side, the coin’s burn rate jumped by 162% to over 6.58 million in the last 24 hours. The circulating supply has dropped to 585 billion after 410 billion were burned from the initial supply. A token burn reduces a coin’s circulating supply and its inflation.

Meanwhile, futures data shows that activity in the market is doing well. The futures open interest rose to $62.8 million on Wednesday, up sharply from last week’s low of $53 million. Rising open interest is a sign that demand is rising in the futures market.

Shiba Inu’s volume in the spot market has also continued rising this week. It jumped to over $143 million, up from below $100 million last week.

Another potential catalyst for the token is the latest developments in the Middle East, where Donald Trump is seeking to de-escalate the crisis after the stock market dropped and crude oil prices surged to the highest point since 2022.

Shiba Inu Coin price technical analysis 

A look at the three-day chart shows that the coin has remained in a bear market this year. This decline, however, is losing momentum as evidenced by the Average Directional Index, which has moved sideways since January. 

On the positive side, the coin has formed a large falling wedge pattern, which is made up of two descending and converging trendlines. There are signs that the two lines are nearing their confluence, which is where bullish breakouts normally happens.

At the same time, the Stochastic Relative Strength Index has moved upwards from 20 in January to 55 today. That is a sign that it has formed a bullish divergence pattern.

Therefore, the most likely SHIB price prediction is bullish, with the next key target being at the 50-day Exponential Moving Average level at $0.0000080. The bullish view will become invalid if it drops below the year-to-date low.

Pioneers await additional upgrades and potential ecosystem expansion this week.

Pi Network, a crypto project often surrounded by controversy, has been drawing renewed attention lately after the Core Team announced a series of upgrades and key developments.

In the days ahead, further updates may emerge that could influence PI’s price.

What Happened and What’s Next?

Earlier this month, the team behind the project revealed that the protocol v19.9 migration was successfully completed, while the next version, v20.2, is scheduled for release later this week, or around March 12.

Another notable development was the newly revealed case study showing how Pi Nodes could be leveraged as a distributed network for AI computing and model training.

Beyond the expected protocol upgrade, the community’s attention has shifted to March 14, widely known as Pi Day for its symbolic resemblance to the mathematical constant π (3.14). In 2025, Pi Network expanded its ecosystem around that date, with many speculating that a similar move might occur this year.

Some community members hope for a major listing on Pi Day, whereas others believe a key announcement from the Core Team is more likely.

PI Remains Trending

The native token of Pi Network is among the best performers from crypto’s top 100, with its price surging by roughly 30% over the past week. A few days ago, it briefly climbed to a three-month peak of $0.23, while currently it is worth $0.22 (per CoinGecko’s data).

You may also like:

Its impressive rise naturally drew the attention of traders and investors, pushing PI into the spotlight. At one point, it even became the top-trending cryptocurrency on CoinGecko. Although the token has cooled off slightly, it remains among the platform’s 15 most-searched digital assets.

Sell-Off on the Way?

Over the past few days, there has been an evident shift of PI tokens from self-custody to centralized exchanges. Data shows that approximately 4.8 million coins have been transferred to trading venues in the last 24 hours alone, thus bringing the total number to 454.1 million. This doesn’t directly imply a short-term price collapse, although the development is often interpreted as a pre-sale step.

Moreover, PI’s Relative Strength Index (RSI) briefly crossed above the bearish mark of 70 and remains quite close to it. This means that the asset has entered overbought territory and could be headed for a pullback. Conversely, anything below 30 is considered a buying opportunity.

The same analyst also noted that BTC is currently running the “oldest playbook in markets.”

Merlijn The Trader, a popular crypto analyst on X, indicated that quantitative tightening had just ended, which has historically preceded massive bitcoin rallies.

He has remained highly bullish on BTC’s mid- to long-term price trajectory, noting that the cryptocurrency is currently in its second phase of manipulation before it heads back above $100,000.

QT Ending: BTC to Millions of $?

Although the official QT ending was determined to be December 1, 2025, Merlijn focused on the more macro bitcoin picture, comparing the same scenario from 2019. At the time, the US Fed also pivoted from its monetary strategy, which was among the propellers behind bitcoin’s surge from a $3,000 low to a $69,000 high within a few years.

He believes the macro trigger and the demand zones are the same now, and noted that if BTC maintains the $70,000 level, the “rally begins.” If it drops below $60,000, then the accumulation extends.

If BTC is to stage such a remarkable rally now of 2,200%, its price tag would skyrocket to over $1.6 million per unit. Needless to say, it sounds rather unimaginable now, but bitcoin has proven in the past that it tends to prove people wrong.

QUANTITATIVE TIGHTENING JUST ENDED. AGAIN.

Last time QT ended in 2019, Bitcoin went from $3K to $69K.

Advertisement

Same macro trigger. Same demand zone. Right now.

Above $70K: the rally begins.
Below $60K: accumulation extends.

The Fed just fired the starting gun.
Most people missed it. pic.twitter.com/7pKUq1sQdG

— Merlijn The Trader (@MerlijnTrader) March 10, 2026

Advertisement

In a separate post, the analyst noted that bitcoin’s accumulation phase is done, and the asset is in its second stage of manipulation, which is “happening now.” Phase 3 would be the distribution, where BTC will head into a six-digit price territory. He noted that $65,000 is the “last stop before the final phase.”

You may also like:

“Hold it: the move begins. Lose it: manipulation isn’t finished yet,” he added.

$80K Next?

As BTC climbed to $71,000 earlier today, Michaël van de Poppe commented that $75,000 should be next, followed by $80,000 this month. While focusing on the more short-term price moves of BTC, the analyst warned that this is “not a V-shape type of recovery, but easily a mean reversion bounce on higher timeframes.”

Interestingly, he argued that the altcoins would perform more impressively during this phase.

There we go.

Markets are breaking upwards, and #Bitcoin is already at $71K.

Advertisement

I think that we’ll see $75K and potentially $80K during this month.

Not a V-shape type of recovery, but easily a mean reversion bounce on higher timeframes.

I would assume that #Altcoins will be… pic.twitter.com/aQXV5Wliej

— Michaël van de Poppe (@CryptoMichNL) March 10, 2026

Advertisement

TLDR

• First quarter revenue climbs 3.9% year-over-year, topping $2.19B consensus.
• Earnings per share lands at $0.83, falling short of $0.87 projection, pressuring shares 1.28% lower.
• Competitor results vary: Tetra Tech advances while Pitney Bowes recovers ground.
• Wall Street keeps $54.67 average price objective intact through current headwinds.
• Top-line momentum persists while profitability concerns weigh on investor confidence.

Shares of ABM Industries Incorporated (ABM) retreated to $43.28, declining 1.28% following the publication of first quarter financial results. The facility services provider posted quarterly revenue totaling $2.2 billion, marginally surpassing the Street’s $2.19 billion projection. Earnings per share, however, registered at $0.83, falling below the anticipated $0.87 figure.

ABM Industries Incorporated, ABM

Top-line performance expanded 3.9% compared to the prior year period, an improvement over the previous year’s corresponding quarter growth rate of 2.2%. Wall Street consensus figures remained relatively unchanged in the weeks leading up to the announcement, signaling expectations for dependable performance. The company has consistently delivered revenue results that meet or modestly surpass analyst projections.

The stock retreated despite exceeding revenue estimates as bottom-line results underwhelmed investors. Full-year earnings guidance continues to align with Street expectations. Trading activity demonstrates downward pressure on the equity despite maintaining solid revenue expansion.

Q1 Performance and Peer Comparisons

ABM’s revenue trajectory stands in contrast to comparable companies operating in industrial and environmental services sectors. Tetra Tech reported a 13.4% revenue contraction yet exceeded consensus estimates, while Pitney Bowes experienced a 7.5% decline and failed to meet projections. Despite revenue challenges, Tetra Tech shares climbed 3%, and Pitney Bowes equity jumped 8.6% following quarterly disclosures.

The industrial services category demonstrates divergent performance amid macroeconomic volatility and possible policy shifts. The broader segment has lagged, with securities declining 4.3% on average throughout the previous month. ABM’s equity decreased 6.2% over the identical timeframe, reflecting greater-than-average vulnerability.

Wall Street analysts maintain a consensus price objective of $54.67 for ABM, substantially above today’s $43.28 trading level. This differential indicates expectations for sustained appreciation over extended horizons, although immediate results present obstacles. The company continues navigating margin headwinds while preserving consistent top-line expansion.

Earnings Revisions and Financial Health

ABM recorded four upward EPS estimate adjustments and three downward revisions during the past 90 days. This divergence in analyst opinion underscores uncertainty regarding profitability metrics and operational effectiveness. The organization’s financial health rating stands at “fair performance,” indicating moderate resilience.

First quarter revenue modestly exceeded consensus projections, yet the earnings disappointment underscores expense challenges and tempered profit advancement. Analysts anticipate the company will sustain reliable revenue trajectory throughout the balance of the fiscal year. Stock valuation reflects a blend of measured growth and earnings underperformance.

ABM continues serving a competitive industrial services marketplace while navigating economic variability. Revenue consistency contrasts with eroding profit margins, generating divergent investor sentiment. The equity trades well beneath analyst price objectives despite a track record of achieving revenue benchmarks.

Key Takeaways

• Shares of MiNK Therapeutics (INKT) climbed 80% on Tuesday following the announcement of a strategic partnership with C-Further.
• The collaboration focuses on developing therapies targeting PRAME, an antigen present in various childhood cancers such as leukemia and sarcomas.
• MiNK stands to gain approximately $1.1 million in milestone-based, non-dilutive financing.
• The company will also earn a double-digit percentage of future commercial revenue from the program.
• MiNK retains flexibility to pursue additional oncology partnerships, as this deal is non-exclusive.

Shares of MiNK Therapeutics surged 80% during Tuesday’s trading session after the biotechnology firm unveiled a strategic collaboration with C-Further, a consortium dedicated to advancing pediatric oncology treatments.

MiNK Therapeutics, Inc., INKT

The partnership aims to create a PRAME-targeted invariant natural killer T (iNKT) cell therapy designed specifically for pediatric cancer patients. PRAME represents a tumor-associated antigen present in numerous childhood malignancies.

According to the terms, MiNK Therapeutics will obtain roughly $1.1 million in non-dilutive capital. This financing structure allows the company to secure resources without diluting existing shareholder equity.

The funding will be disbursed as the company achieves predetermined scientific objectives throughout the preclinical candidate selection and translational development phases. Additionally, MiNK will capture a double-digit portion of any eventual commercial revenues generated by the therapy.

MiNK’s proprietary iNKT technology operates as a ready-to-use, off-the-shelf treatment option. The therapy is sourced from healthy donors, pre-manufactured, and administered without requiring HLA matching or lymphodepleting chemotherapy protocols — offering significant logistical benefits.

The initiative specifically targets PRAME, which appears at elevated levels across multiple pediatric cancer types including various sarcomas, acute myeloid leukemia, and medulloblastoma. Since PRAME expression remains minimal in normal tissues, it presents an ideal candidate for therapeutic intervention.

C-Further operates with support from Cancer Research Horizons, LifeArc, and Great Ormond Street Hospital Charity. The consortium’s mission centers on fast-tracking immunotherapy development for children battling cancers with limited existing treatment alternatives.

MiNK Therapeutics will function as the primary industry collaborator for this project. The company contributes its iNKT technology platform, genetic engineering competencies, and translational development knowledge to the partnership.

Academic Research and Preclinical Studies

Researchers from the University of Southampton will conduct autonomous preclinical investigations. These studies will assess anti-cancer efficacy, cellular persistence, and safety profiles across various pediatric cancer models, including systems derived from actual patient tumors.

The objective involves identifying one optimal clinical candidate. This lead candidate would subsequently advance toward initial human trials in pediatric populations.

This collaboration represents among the earliest programs selected by the C-Further consortium following its establishment. This positioning places MiNK among the first companies integrated into the consortium’s operations.

Flexibility Maintained Through Non-Exclusive Terms

The partnership operates under non-exclusive terms. This structure allows MiNK to simultaneously advance its iNKT platform across different cancer indications and establish additional collaborative relationships.

This framework holds significance for stakeholders. It ensures the C-Further collaboration doesn’t restrict MiNK to a singular development pathway — enabling parallel expansion of the company’s broader therapeutic pipeline.

MiNK’s iNKT technology functions by merging PRAME-specific tumor recognition with the distinctive immunological properties of iNKT cells, which connect innate and adaptive immune system functions.

The therapeutic program seeks to achieve targeted tumor destruction while simultaneously activating coordinated immune responses throughout the tumor microenvironment.

INKT stock finished Tuesday’s session with an 80% gain. Prior to this announcement, the shares had been trading at relatively depressed levels, making this surge a dramatic market response to the partnership news.